Jack Davis Email & Phone Number

The IntelliGenome team has developed the first molecular diagnostic detection assay in the world using CRISPR technology to detect low abundance nucleic acid in small volume blood samples. We have also developed a high-efficiency DNA polymerase-based and thermostable protein-enhanced CRISPR fluorescence detection system, and further developed an.

Global IVD distribution network. Delivering a 510k FDA approved Drugs of Abuse testing portfolio in the US market in collaboration with EuroMed USA. Commercializing a blood-based TB assay run with PCR and CRISPER technology which is scheduled for submission to the FDA for Breakthrough Device Designation in Q3 2024.

Frankfurt Am Main, DE

Corgenix, founded in 1990, is medical diagnostics company based in Broomfield, Colorado. We are a full service partner to the Diagnostics and Pharmaceutical industry, offering a broad and unique array of products and capabilities. We are experts in the development, tech transfer, registration, manufacturing and commercialization of specialty diagnostics.

• Scientific laboratory is a full service clinical lab that serviced the long term care, substance abuse, detox and recovery space, mental health facilities and pain management clinics.
• Revenue growth of $326,000 YOY for blood 2017, $344,400 YOY 2018
• Overall accession growth of 3,824 FP/GP/Int. Med. Call points (non-treatment center)
• Grew toxicology revenue by $730,000 YOY 2017, $613,000 YOY 2018
• 9 reps stayed $8,600 under expense budget of $100,000
• Grew revenue per accession from 13.4% to 14.6% over 2 years

• Launched pharmacogenetics (2012) and advanced lipids (2014). Developed programs based on clinical, procedural and financial utility.
• Grew daily patient encounters by 60% YOY, revenue per requisition by 63% YOY
• Added 3 clients per month per territory in lipids (4 territories total) 200 tests per new client
• Opened patient service center 31% under budget, grew draws 21% month over month for 6 months.
• Grew tests per requisition from 6 to 15 YOY, revenue per requisition to over $300
• Innovation cut turn around time from 11 to 5 days through auto reflex program.

• ResponseDX: Lung™, ResponseDX: Colon™, ResponseDX: Gastric™, ResponseDX: Melanoma™—to help physicians with therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC) EGFR, EML4-ALK, c-Met.
• Added 1 new account for first 8 months, grew tests ordered by 546 YOY
• Grew total panels ordered by 11% resulting in revenue growth of $313,000
• 112% quota attainment YOY in 2011, quota attainment 104% YOY in 2012
• Ended $12,189.00 under expense budget YOY 2012 through efficient territory mgmt.Related Targeted Therapies:Erlotinib (Tarceva), Pemetrexed (Alimta), Cetuximab (Erbitux), Bevacizumab Injection (Avastin), Carboplatin.

Cherry Hill, NJ, US

• Cancer Genetics, Inc. (CGI) is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and.
• Grew flow cytometry submissions by 45 cases
• Grew Zap-70/CD38 by 38 cases
• Increased BRAF submissions for lung by 103 cases, 100% growth YOY
• Increased CLL complete submissions by 28 cases, 100% growth YOY
• Grew full case referrals by 67% YOY, 18 total cases

Burlington, North Carolina, US

• LabCorp is a full service national laboratory servicing all specialties and testing for all disease statesLabCorp, Eastern U.S. (U.S. Labs/Esoterix/Dianon)Regional Director of Business Development Directed team of 10.
• Grew team from 4 to 10 associates. Hired, trained and managed 6 new reps plus 4 tenured reps in $42 Million dollar territory.
• Increased histology volume by 11% territory wide
• Increased tech-only IHC by 655 per month for 4% growth YOY 2009
• Increased Virtual Image (breast markers only) by 3% per territory on average
• Increased flow cytometry cases by 4% per territory on average over 2 years

Cortlandt Manor, NY, US

• Polymedco, Inc. operates as a marketing and distribution company in the clinical laboratory marketplace. The company offers reagents/kits, including chemistry tests in various platforms and packaging configurations.
• President’s Club Award Winner 1999
• Led company with 2200 BTA Stat test submissions for recurrent bladder cancer
• Grew specialty chemistries with 16 new HCA hospitals worth $276,000 YOY growth focusing on direct LDL, fructosamine, microalbumin and HsCRP
• 104% or better quota attainment for 5 straight years.

Irving, Texas, US